Evidence map›Paper›PMID 10896725›Full record

ArticleThe Journal of physiology2000

Ca2+-calmodulin-dependent protein kinase II-dependent activation of contractility in ferret aorta.

I Kim, H D Je, C Gallant, Q Zhan, D V Riper, J A Badwey, H A Singer, K G Morgan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Enhanced KCl-mediated contractility and CaAmerican journal of physiology. Heart and circulatory physiology · 2020
    Article
  8. Article
  9. Arginase II activity regulates cytosolic CaExperimental & molecular medicine · 2019
    Article
  10. Article
  11. Review
  12. Vascular CaMKII: heart and brain in your arteries.American journal of physiology. Cell physiology · 2016
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Role of various kinases in muscarinic M3 receptor-mediated contraction of longitudinal muscle of rat colon.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

I KimBoston Biomedical Research Institute, Watertown, MA 02472, USA.
H D Je
C Gallant
Q Zhan
D V Riper
J A Badwey
H A Singer
K G Morgan
Boston Biomedical Research Institute · USAlbany Medical Center Hospital · US

Funding

CALCIUM/CALMODULIN ACTIVATED KINIASES IN SMOOTH MUSCLER01HL049426 · NHLBI · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI SINGER, HAROLD A · 1994 to 2019
$6.2M
REGULATION OF CONTRACTION OF BLOOD VESSELSR01HL031704 · NHLBI · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI MORGAN, KATHLEEN G · 1985 to 2009
$3.7M
CONTRACTION OF VASCULAR SMOOTH MUSCLE CELLSR01HL042293 · NHLBI · BOSTON BIOMEDICAL RESEARCH INSTITUTE · PI MORGAN, KATHLEEN G · 1989 to 2004
$1.2M
Calcium/Calmodulin Activated Kinases in Smooth MuscleR56HL049426 · NHLBI · ALBANY MEDICAL COLLEGE · PI SINGER, HAROLD A · 2008 to 2022
$975k
MAPK IN THE CONTRACTILE PHENOTYPE OF SMOOTH MUSCLER01HL056035 · NHLBI · BOSTON BIOMEDICAL RESEARCH INSTITUTE · PI BADWEY, JOHN A · 1996 to 2000
$241k
NHLBI NIH HHS HL31704NHLBI NIH HHS HL42293NHLBI NIH HHS HL56035NHLBI NIH HHS R01 HL031704NHLBI NIH HHS R01 HL042293NHLBI NIH HHS R01 HL049426NHLBI NIH HHS R56 HL049426
6 · The paper itself

Abstract

1. The present study was undertaken to determine whether Ca2+-calmodulin-dependent protein kinase II (CaMKII) participates in the regulation of vascular smooth muscle contraction, and if so, to investigate the nature of the downstream effectors. 2. The contractility of isolated ferret aorta was measured while inhibiting CaMKII either with antisense oligodeoxynucleotides against CaMKII or with the CaMKII inhibitor KN93. 3. Treatment with antisense oligodeoxynucleotides against CaMKII resulted in, on average, a decrease in protein levels of CaMKII to 56 % of control levels and significantly decreased the magnitude of the contraction in response to 51 mM potassium physiological saline solution (KCl). Contraction in response to the phorbol ester DPBA was not significantly affected. 4. The CaMKII blocker KN93 also resulted in a significant decrease in the force induced by 51 mM KCl but caused no significant change in the contraction in response to DPBA or the alpha-adrenoceptor agonist phenylephrine. 5. During contraction with 51 mM KCl, both CaMKII and mitogen-activated protein kinase (MAPK) activity increased, as determined by phospho-specific antibodies. The MAPK phosphorylation level was inhibited by KN93, PD098059 (a MAPK kinase (MEK) inhibitor) and calcium depletion. 6. Myosin light chain (LC20) phosphorylation also increased during contraction with KCl and the increase was significantly blocked by PD098059 as well as by both KN93 and antisense oligodeoxynucleotides to CaMKII. 7. The data indicate that CaMKII plays a significant role in the regulation of smooth muscle contraction and suggest that CaMKII activates a pathway by which MAPK activation leads to phosphorylation of LC20 via activation of myosin light chain kinase.

Indexed as

AnimalsAorta, ThoracicBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Enzyme InhibitorsFerretsFlavonoidsIn Vitro TechniquesMitogen-Activated Protein KinasesMuscle ContractionMuscle, Smooth, VascularMyosin Light ChainsOligodeoxyribonucleotides, AntisensePhosphorylation2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase Type 2Enzyme InhibitorsFlavonoidsKN 93Mitogen-Activated Protein KinasesMyosin Light ChainsOligodeoxyribonucleotides, AntisensePotassium ChlorideSulfonamides

Identifiers

PMID10896725
PMCPMC2270028
OpenAlexW1988585626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.